SCHEMBL15540924

SCHEMBL15540924

COc1cc(N)ccc1N1CCC(F)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A1 P22736 2/20 0.51
ALDH1A1 P00352 7/20 0.49
HTT P42858 2/20 0.49
ALDH1A3 P47895 1/20 0.43
MAPT P10636 8/20 0.41
GAA P10253 6/20 0.41
KDM4E B2RXH2 4/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
THRB P10828 1/20 0.41
PTK2B Q14289 1/20 0.41
LMNA P02545 1/20 0.41
TSHR P16473 1/20 0.41
MAPK1 P28482 1/20 0.41
HSD17B10 Q99714 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
DRD2 P14416 3/20 0.40
LRRK2 Q5S007 2/20 0.40
HTR2A P28223 2/20 0.40
APOBEC3G Q9HC16 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17265438 0.89 NR4A1 (0.53) NR4A1ALDH1A1HTTALDH1A3MAPT
SCHEMBL29989590 0.88 ALDH1A1 (0.65) NR4A1ALDH1A1HTTALDH1A3MAPT
SCHEMBL15358685 0.87 NR4A1 (0.61) NR4A1ALDH1A1HTTALDH1A3MAPT
SCHEMBL15244065 0.86 NR4A1 (0.50) NR4A1ALDH1A1HTTALDH1A3MAPT
SCHEMBL13723401 0.86 NR4A1 (0.50) NR4A1ALDH1A1HTTALDH1A3MAPT
SCHEMBL25190349 0.85 NR4A1 (0.47) NR4A1ALDH1A1HTTALDH1A3MAPT
SCHEMBL30336504 0.85 NR4A1 (0.47) NR4A1ALDH1A1HTTALDH1A3MAPT
SCHEMBL5395255 0.85 NR4A1 (0.49) NR4A1ALDH1A1HTTALDH1A3MAPT
SCHEMBL10035924 0.84 NR4A1 (0.48) NR4A1ALDH1A1HTTALDH1A3MAPT
SCHEMBL29399632 0.84 NR4A1 (0.48) NR4A1ALDH1A1HTTALDH1A3MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013188856-A1 IMIDAZOPYRAZINE SYK INHIBITORS GILEAD CONNECTICUT, INC. (US) 2013-12-19 WO disclosed